DE60317561D1 - Vorrichtung und verfahren zur herstellung von autologem thrombinserum - Google Patents

Vorrichtung und verfahren zur herstellung von autologem thrombinserum

Info

Publication number
DE60317561D1
DE60317561D1 DE60317561T DE60317561T DE60317561D1 DE 60317561 D1 DE60317561 D1 DE 60317561D1 DE 60317561 T DE60317561 T DE 60317561T DE 60317561 T DE60317561 T DE 60317561T DE 60317561 D1 DE60317561 D1 DE 60317561D1
Authority
DE
Germany
Prior art keywords
reaction chamber
thrombin serum
autologous thrombin
producing autologous
activating agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60317561T
Other languages
English (en)
Other versions
DE60317561T2 (de
Inventor
Daniel Mcginnis
Cherylyn Voorhees
Hubert Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Livanova Holding USA Inc
Original Assignee
Sorin Group USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sorin Group USA Inc filed Critical Sorin Group USA Inc
Application granted granted Critical
Publication of DE60317561D1 publication Critical patent/DE60317561D1/de
Publication of DE60317561T2 publication Critical patent/DE60317561T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Enzymes And Modification Thereof (AREA)
DE60317561T 2002-12-23 2003-12-18 Vorrichtung und verfahren zur herstellung von autologem thrombinserum Expired - Lifetime DE60317561T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US328419 2002-12-23
US10/328,419 US20040120942A1 (en) 2002-12-23 2002-12-23 Device and process for the preparation of autologous thrombin serum
PCT/US2003/040804 WO2004058943A2 (en) 2002-12-23 2003-12-18 Device and process for the preparation of autologous thrombin serum

Publications (2)

Publication Number Publication Date
DE60317561D1 true DE60317561D1 (de) 2007-12-27
DE60317561T2 DE60317561T2 (de) 2008-09-04

Family

ID=32594463

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60317561T Expired - Lifetime DE60317561T2 (de) 2002-12-23 2003-12-18 Vorrichtung und verfahren zur herstellung von autologem thrombinserum

Country Status (7)

Country Link
US (1) US20040120942A1 (de)
EP (1) EP1576153B1 (de)
JP (1) JP4886194B2 (de)
AT (1) ATE378402T1 (de)
AU (1) AU2003301200A1 (de)
DE (1) DE60317561T2 (de)
WO (1) WO2004058943A2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062828A1 (en) * 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
AU2003249642A1 (en) 2002-05-24 2003-12-12 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
CN101317855A (zh) * 2003-01-27 2008-12-10 哈维斯特技术公司 从抗凝全血生产的自体或同种促凝剂
EP1848473B1 (de) * 2005-02-07 2013-05-22 Hanuman LLC Plasmakonzentrationsvorrichtung
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US8753690B2 (en) 2008-02-27 2014-06-17 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009108890A1 (en) 2008-02-27 2009-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) * 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
JP5442310B2 (ja) * 2009-04-23 2014-03-12 旭化成メディカル株式会社 トロンビン溶液の調製方法
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
CN102573790B (zh) 2009-08-27 2017-03-22 拜欧米特生物制剂有限责任公司 用于产生白介素‑1受体拮抗剂的可植入装置
GB201004072D0 (en) * 2010-03-11 2010-04-28 Turzi Antoine Process, tube and device for the preparation of wound healant composition
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
KR20140003398A (ko) 2010-09-03 2014-01-09 바이오멧 바이오로직스, 엘엘씨 인터루킨-1 수용체 길항제를 전달하는 방법 및 조성물
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
US8586324B2 (en) 2011-08-15 2013-11-19 Biomet Biologics, Llc Method and apparatus to create autologous clotting serum
US10849931B2 (en) * 2011-09-30 2020-12-01 Depuy Synthes Products, Inc Compositions and methods for platelet enriched fibrin constructs
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
RU2589648C2 (ru) * 2012-09-25 2016-07-10 Стем Селл Партнерс Ллк Способ и устройство для получения сыворотки с тромбином от одного донора
US9149529B2 (en) * 2012-10-24 2015-10-06 Orthovita, Inc. Stable compositions containing thrombin and methods for preparation and use thereof
ITVR20120229A1 (it) * 2012-11-15 2014-05-16 Bbs Srl Dispositivo pronto all'uso e metodo per la rimozione di interferenti da campioni da sottoporre ad esame microbiologico
US9114190B2 (en) * 2013-02-08 2015-08-25 Laser Spine Institute, Llc Regeneration of spinal discs
US9878011B2 (en) 2013-03-15 2018-01-30 Biomet Biologics, Llc Treatment of inflammatory respiratory disease using biological solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9758806B2 (en) 2013-03-15 2017-09-12 Biomet Biologics, Llc Acellular compositions for treating inflammatory disorders
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
EP3074507B1 (de) 2013-11-26 2022-01-05 Biomet Biologics, LLC Verfahren zur vermittlung von makrophagenphänotypen
ES2645862T3 (es) * 2014-03-17 2017-12-11 Al.Chi.Mi.A. S.R.L. Dispositivo listo para usar y método para eliminar factores interferentes de muestras que se van a someter a examen microbiológico
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
US20170274012A1 (en) * 2014-09-03 2017-09-28 Entegrion, Inc. Acceleration of Reconstitution of Plasma Powder by Mixing with Small Beads
US10441635B2 (en) 2014-11-10 2019-10-15 Biomet Biologics, Llc Methods of treating pain using protein solutions
US9763800B2 (en) 2015-03-18 2017-09-19 Biomet C. V. Implant configured for hammertoe and small bone fixation
CN105181978B (zh) * 2015-09-23 2016-07-20 青岛古高生物科技有限公司 一种凝血酶时间测定试剂及其制备方法
EP3426401B1 (de) 2016-03-10 2021-05-12 Arthrex, Inc. Systeme zur herstellung eines thrombinserums
WO2017156379A2 (en) 2016-03-10 2017-09-14 Arthrex, Inc. Systems and methods for preparing protein enhanced serums
CA3127191A1 (en) 2019-01-21 2020-07-30 Eclipse Medcorp, Llc Methods, systems and apparatus for separating components of a biological sample
PL439627A1 (pl) * 2021-11-24 2023-05-29 Biovico Spółka Z Ograniczoną Odpowiedzialnością System zawierający aktywator zwiększający poziom endogennego inhibitora szlaku Wnt

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5795780A (en) * 1993-06-23 1998-08-18 Bristol-Myers Squibb Company Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5733545A (en) * 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
US5643192A (en) * 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
US5814022A (en) * 1996-02-06 1998-09-29 Plasmaseal Llc Method and apparatus for applying tissue sealant
WO1997040864A1 (en) * 1996-04-30 1997-11-06 Medtronic, Inc. Method for making autologous fibrin sealant
US6274090B1 (en) * 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6472162B1 (en) * 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
EP1381410A2 (de) * 2001-04-09 2004-01-21 Medtronic, Inc. Zentrifugationsverfahren zur isolierung der blutbestandteile, und deren verwendungen

Also Published As

Publication number Publication date
US20040120942A1 (en) 2004-06-24
AU2003301200A1 (en) 2004-07-22
WO2004058943A3 (en) 2005-02-10
AU2003301200A8 (en) 2004-07-22
ATE378402T1 (de) 2007-11-15
JP2006515853A (ja) 2006-06-08
JP4886194B2 (ja) 2012-02-29
EP1576153A4 (de) 2006-01-18
EP1576153A2 (de) 2005-09-21
WO2004058943A2 (en) 2004-07-15
DE60317561T2 (de) 2008-09-04
EP1576153B1 (de) 2007-11-14

Similar Documents

Publication Publication Date Title
DE60317561D1 (de) Vorrichtung und verfahren zur herstellung von autologem thrombinserum
AU2002353022A1 (en) Methods and apparatus for separation of blood components
ATE450479T1 (de) Verfahren zur herstellung von glaskeramikartikeln
BR0311304A (pt) Método e aparelho para a criação de um fluxo de partìculas pulsado
ATE478082T1 (de) Phosphonate, monophosphonamidate, bisphosphonamidate zur behandlung von virenerkrankungen
DE69920945D1 (de) Verfahren zur herstellung von arzneistoffpartikeln
ATE425808T1 (de) Vorrichtung zur effizienten hamodiafiltration
GB0518804D0 (en) Exudialysis tissue cleanser
BR9506198A (pt) Recipiente para guardar produtos de sangue recipiente para guardar sangue processo para armazenar sangue e aparelho para separar sangue
DE60114002D1 (de) VERFAHREN ZUR HERSTELLUNG KRISTALLINEr PARTIKEL ZUR INHALATION
DE602005023133D1 (de) Prozess und reagenzien für extraktion von rns von fraktionierten blutleukozyten
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ATE402211T1 (de) Verfahren zur herstellung von farblosen, lagerstabilen biuretgruppenhaltigen polyisocyanaten
GB0411381D0 (en) Assay method and apparatus
AU2003223990A1 (en) Filtration devices
DE60308164D1 (de) Prozess zur herstellung einer sterilen suspension von corticoid-partikeln zur verabreichung durch inhalation
ATE354439T1 (de) Vorrichtung zur separierung und ausgabe von plasma
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
DE60219927D1 (de) Verfahren zur herstellung von glycopeptid- phosphonat-derivaten
DE60237649D1 (de) Flüssigkeitsfiltrierverfahren
ATE442434T1 (de) Verfahren zur unterdrückung einer immunsystemreaktion gegen gewebe- oder zelltransplantate
ATE361068T1 (de) Wirkstoff zur entfernung einer unerwünschten proteinpopulation aus dem plasma
DE60220001D1 (de) Verfahren zur Herstellung von (Meth)acrylaten von Alkylimidazolidonen
DE502007004937D1 (de) Verfahren und vorrichtung zur behandlung von schüttgut mit einem physikalischen plasma bei atmosphärendruck
EP1679117A3 (de) Adsorptionssystem zur Entfernung von Viren und viralen Bestandteilen aus Flüssigkeiten, insbesondere aus Blut und Blutplasma

Legal Events

Date Code Title Description
8364 No opposition during term of opposition